Remove 2027 Remove Compounding Remove Immunization
article thumbnail

Social Media Significantly Influences Attitudes, Behaviors Toward Skin Health

Drug Topics

billion people used social media in 2021, and this number is likely to grow to almost 6 billion in 2027. Social media browsing is the most popular online activity,” wrote authors of the study. According to the statistics, [over] 4.26 In April 2023, a total of 4.8 billion people, or 59.9% of the world’s population, were social media users.”

article thumbnail

Empress Therapeutics emerges with $50m to fund small molecule development

Pharmaceutical Technology

With this pipeline, Empress hopes to address unmet clinical needs in immune and inflammatory conditions, and metabolic, neurologic, oncologic, and pain disorders. Analysts forecast the biologics market to be worth $120 billion more than small molecules by 2027. Murray KcKinnon, PhD He joined Empress as chief scientific officer.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Jiashu Xie, PhD

Blog: Ask a Student Pharmacist

Jiashu Xie, PhD eomizowh Wed, 06/21/2023 - 10:11 Expand all + Biography Research Summary Current research in the Pharmacokinetics (PK) lab has focused on profiling the in vitro ADME (absorption, distribution, metabolism, and excretion) and in vivo PK properties of lead compounds from medicinal chemistry efforts.

article thumbnail

FDA Approves Immunoglobulin Formulation With Low IgA Content for Primary Immunodeficiency

Pharmacy Times

Takeda will discontinue Gammagard S/D by December 2027, transitioning to the new low IgA formulation. Pharmacists are essential in evaluating patient suitability for Gammagard Liquid ERC, considering IgA levels and potential hypersensitivity reactions.

FDA 97
article thumbnail

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC

Pharmacy Times

Completion Date (Estimated): June 2027 “For people living with advanced ROS1+ lung cancer, who tend to be diagnosed at a younger age, having another treatment option can make a real difference for them and their loved ones,” Janet Freeman-Daily, cofounder and president of The ROS1ders, said in a news release.

FDA 73
article thumbnail

Subcutaneous Biologics Market Analysis: Current Trends and Future Outlook

Roots Analysis

Moreover, protein-based drugs are also well tolerated inside the body, thereby reducing the chances of causing any immune response in the body. This can be attributed to the fact that encapsulation technology allows tailored release of the active compounds, enabling sustained or targeted delivery to specific sites in the body.

article thumbnail

High biologics demand spurs need for greater contract manufacturing

Pharmaceutical Technology

. “Biologics products may contain proteins that control the action of other proteins and cellular processes, genes that control production of vital proteins, modified human hormones, or cells that produce substances that suppress or activate components of the immune system.